CHEX-seq detects single-cell genomic single-stranded DNA with catalytical potential

Youtao Lu, Jaehee Lee, Jifen Li, Srinivasarao Allu, Jinhui Wang, Hyun‐Bum Kim, Kevin Bullaughey, Stephen Fisher, C. Erik Nordgren, Jean G. Rosario, Stewart A. Anderson, Alexandra V. Ulyanova, Steven Brem, H. Isaac Chen, John A. Wolf, M. Sean Grady, Sergei A. Vinogradov, Junhyong Kim, James EberwineNature Communications 2023 · DOI

TL;DR

Researchers have developed CHEX-seq, a novel method to map single-stranded DNA (ssDNA) within individual cells in situ. This technique reveals dynamic ssDNA landscapes linked to gene expression and, surprisingly, uncovers endogenous ssDNA regions with catalytic potential, suggesting a new layer of genomic function.

What Problem Does This Paper Address?

Understanding how DNA's structure influences its function is crucial. While double-stranded DNA (dsDNA) is the canonical form, transient single-stranded DNA (ssDNA) is known to be involved in critical processes like transcription, DNA repair, and replication. However, mapping these ssDNA regions within intact, individual cells has been challenging. Existing methods often require cell lysis, cross-linking, or are limited to bulk analysis, losing spatial and cellular resolution. This gap hinders our ability to study the dynamic role of ssDNA in cellular homeostasis and disease.

Methods

The core innovation is CHEX-seq (Chromatin Exposed). It utilizes a custom oligonucleotide probe with three key features:

  1. 5' Barcode: For multiplexing samples.
  2. Degenerate Sequence: Designed to anneal to ssDNA in fixed cells.
  3. 3' Lightning Terminator: A photo-reversibly blocked nucleotide with a fluorescent tag.

The process involves:

  1. Annealing: CHEX-seq probes bind to ssDNA regions in fixed cells.
  2. Photoactivation: A UV laser cleaves the terminator, freeing a 3'-OH group.
  3. In Situ cDNA Synthesis: The freed 3'-OH acts as a primer for DNA polymerase to synthesize a complementary DNA strand, effectively "copying" the ssDNA region.
  4. Sequencing Prep: The synthesized cDNA is amplified (aRNA amplification), converted to dsDNA, PCR amplified, and sequenced.

This light-activated, in situ approach allows for ssDNA mapping while preserving cellular architecture and enabling single-cell resolution.

Datasets

  • Human K562 cells: Used for benchmarking CHEX-seq and comparing it to other chromatin assays (ATAC-seq, DNase-seq, FAIRE-seq) and transcriptome data (RNA-seq, GRO-seq).
  • Mouse and human brain cells: Primary cultures and fixed tissue sections were used to demonstrate CHEX-seq's applicability in different cell types and biological contexts.
  • Publicly available datasets: ENCODE data for K562 and human/mouse brain epigenomes were used for comparative analysis.

Key Insights and Ideas

  • ssDNA is dynamically regulated: CHEX-seq revealed that the amount and location of ssDNA change significantly in response to cellular perturbations (e.g., TPA treatment), highlighting its role in cellular plasticity.
  • ssDNA near TSS is linked to transcription: A strong correlation was observed between CHEX-seq priming sites near Transcription Start Sites (TSS) and gene expression levels, suggesting ssDNA accessibility as a marker for transcriptional potential.
  • Mitochondrial ssDNA detected: CHEX-seq successfully mapped ssDNA within the mitochondrial genome, offering new insights into mitochondrial function.
  • Endogenous ssDNA with catalytic activity: Perhaps the most surprising finding is the identification of specific ssDNA loci in the genome that exhibit catalytic activity in vitro, specifically for porphyrin metalation. This suggests that ssDNA might not just be a passive template but can actively participate in biochemical reactions.

Key Results

  • Genome-wide ssDNA mapping: CHEX-seq successfully mapped ssDNA regions across the genome in single cells, identifying hotspots in intergenic regions, introns, and near TSS.
  • Comparison with other assays: CHEX-seq showed distinct patterns compared to dsDNA-focused assays like ATAC-seq, highlighting its unique ability to capture ssDNA. It demonstrated a strong overlap with actively transcribed genes.
  • Dynamic ssDNA changes: Treatment of K562 cells with TPA led to rapid and time-dependent changes in TSS ssDNA enrichment, with a sharp decrease at 15 minutes post-treatment.
  • Catalytic ssDNA identified: Six out of nine tested CHEX-seq predicted ssDNA regions showed in vitro catalytic activity for porphyrin metalation, with some requiring a Pb2+ cofactor.
  • FISH validation: Single-molecule FISH confirmed the presence of endogenous ssDNA loci predicted by CHEX-seq.

Limitations and Future Work

  • Background signal: The authors acknowledge a higher background signal in bulk controls compared to single-cell data, which they attribute to the sensitivity prioritization. Future work may focus on optimizing probe design and photoactivation efficiency.
  • Multiplexing and throughput: While CHEX-seq is powerful, scaling it to high throughput for thousands of cells in tissue sections will require automated dynamic photomasking and AI algorithms.
  • In vivo catalytic activity: The in vitro catalytic activity of identified ssDNA regions needs to be demonstrated in vivo, which is challenging due to the need for specific conditions (e.g., Pb2+ cofactor). Future studies will explore this further.
  • Broader genomic roles: The authors suggest that CHEX-seq can be extended to study other genomic processes like DNA repair and replication, and that further technical improvements could enable multiplexing with other molecular analyses (e.g., protein detection) in the same cell. The potential for ssDNA to act as "genomic DNAzymes" in various biological processes is a significant avenue for future research.

Summary updated

Abstract

Genomic DNA (gDNA) undergoes structural interconversion between single- and double-stranded states during transcription, DNA repair and replication, which is critical for cellular homeostasis. We describe "CHEX-seq" which identifies the single-stranded DNA (ssDNA) in situ in individual cells. CHEX-seq uses 3'-terminal blocked, light-activatable probes to prime the copying of ssDNA into complementary DNA that is sequenced, thereby reporting the genome-wide single-stranded chromatin landscape. CHEX-seq is benchmarked in human K562 cells, and its utilities are demonstrated in cultures of mouse and human brain cells as well as immunostained spatially localized neurons in brain sections. The amount of ssDNA is dynamically regulated in response to perturbation. CHEX-seq also identifies single-stranded regions of mitochondrial DNA in single cells. Surprisingly, CHEX-seq identifies single-stranded loci in mouse and human gDNA that catalyze porphyrin metalation in vitro, suggesting a catalytic activity for genomic ssDNA. We posit that endogenous DNA enzymatic activity is a function of genomic ssDNA.
BibTeX
@inproceedings{lu2023chex,
  author = {Youtao Lu and Jaehee Lee and Jifen Li and Srinivasarao Allu and Jinhui Wang and Hyun‐Bum Kim and Kevin Bullaughey and Stephen Fisher and C. Erik Nordgren and Jean G. Rosario and Stewart A. Anderson and Alexandra V. Ulyanova and Steven Brem and H. Isaac Chen and John A. Wolf and M. Sean Grady and Sergei A. Vinogradov and Junhyong Kim and James Eberwine},
  title = {{CHEX-seq detects single-cell genomic single-stranded DNA with catalytical potential}},
  booktitle = {Nature Communications},
  year = {2023},
  doi = {10.1038/s41467-023-43158-6},
}
Figure